Halozyme Therapeutics Stock News & Updates
[WKN: A0DLHS | Symbol: HALO]
Halozyme Therapeutics
Halozyme Therapeutics - ENHANZE Licensing Revenues Boost Results Significantly!
Halozyme Therapeutics - ENHANZE Licensing Revenue Drives new Records in Revenue and Earnings!
Business Drivers: The US biotech company Halozyme Therapeutics (HALO) specializes in products within...
Halozyme Reports Strong Quarterly Results and Raises Full-Year Outlook - Stock with Up-Gap!
Halozyme is a biopharmaceutical technology company with a unique business model, as it does not develop...
Halozyme Therapeutics: Rapidly Rising Licensing Fees Make Halozyme a Biotech Top Pick
The stock of Halozyme was one of the first stocks I presented in this section on July 3, 2024. Shortly...
- ‹
- 1
- ›